Is Novartis AG overvalued?

Novartis AG (NVS) looks fairly valued — trading about 1% above its fair value.

Fairly valued

Price

$154.55

Fair value

$153.54

Current P/E

17.8

Normal P/E

17.7

Market cap

$293.76B

Dividend yield

3.1%

Return on equity

29.9%

Sector

Healthcare

Fair value compares NVS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 16 Aug 2026.

Related stocks